MDT - Why Axonics Modulation Technologies Is Skyrocketing 24.5% Today
After management offered an early look at the company's fourth-quarter financial results, Axonics Modulation Technologies (NASDAQ: AXNX) shares are rocketing 24.5% higher at 1:00 p.m. EST on Thursday.
Axonics secured Food and Drug Administration approval to begin marketing its implantable treatment for urinary and fecal incontinence in November 2018, and this morning, management reported preliminary fourth-quarter sales suggesting a brisk launch. Specifically, fourth-quarter revenue is expected to be $10 million, resulting in full-fiscal-year revenue of approximately $14 million.
IMAGE SOURCE: GETTY IMAGES.